All In Biotech

Drug Trial Radar · NCT04593459

Probiotic Intervention in PCOS

Probiotic Dietary Intervention in Polycystic Ovary Syndrome (PCOS) - A Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Mar 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 112 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

112

Actual

Start

Nov 3, 2020

Primary completion

Oct 16, 2023

Study completion Oct 16, 2023

Sponsor

Lead sponsor
Medical University of GrazAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Institut AllergoSan Pharma GmbH; Winclove Probiotics B.V.
First posted
Oct 20, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators are conducting a double-blinded randomized controlled trial to determine whether a probiotic mixture is effective in reducing PCOS-related symptoms. For this purpose, 180 participants will be recruited in three intervention arms (Probiotic, Placebo and Metformin), with 60 participants per arm. The intervention period will last 6 months, with extensive medical history, blood work, urine and stool analysis at the beginning and the conclusion of the trial.

Conditions

  • Polycystic Ovary Syndrome

Interventions

  • ProbioticDietary supplement

    See Arm description

  • Metformin HydrochlorideDrug

    See Arm description

  • Probiotic PlaceboDietary supplement

    See Arm description

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Free testosteroneTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical University of Graz, Division of Endocrinology and Diabetology

    Graz, Styria, Austria

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.